A wide-ranging primer on how recent scientific and technological advances are making aging a tractable target for clinical intervention.
Key Takeaways
- ER 100 received clearance to begin the first human epigenetic reprogramming trials
- OSK gene reprogramming can reportedly reset the epigenetic clock in human cells
- Same epigenetic approach restored vision in mice and is now in human testing